A detailed history of Sunburst Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sunburst Financial Group, LLC holds 1,998 shares of AMGN stock, worth $588,470. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,998
Previous 1,998 -0.0%
Holding current value
$588,470
Previous $624,000 3.04%
% of portfolio
0.17%
Previous 0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$262.75 - $319.31 $80,401 - $97,708
-306 Reduced 13.28%
1,998 $624,000
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $34,953 - $42,192
-130 Reduced 5.34%
2,304 $655,000
Q4 2023

Jan 08, 2024

BUY
$255.7 - $288.46 $98,188 - $110,768
384 Added 18.73%
2,434 $701,000
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $6,559 - $8,143
-30 Reduced 1.44%
2,050 $550,000
Q2 2023

Jul 11, 2023

SELL
$214.27 - $253.37 $8,570 - $10,134
-40 Reduced 1.89%
2,080 $461,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $12,825 - $16,296
56 Added 2.71%
2,120 $0
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $8,305 - $9,366
37 Added 1.83%
2,064 $465,000
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $1,789 - $2,048
-9 Reduced 0.44%
2,027 $456,000
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $6,792 - $7,958
32 Added 1.6%
2,036 $433,000
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $2,569 - $2,850
11 Added 0.55%
2,004 $488,000
Q4 2020

Jan 20, 2021

SELL
$216.38 - $257.67 $10,819 - $12,883
-50 Reduced 2.45%
1,993 $458,000
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $6,527 - $8,010
33 Added 1.64%
2,043 $482,000
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $26,607 - $35,288
146 Added 7.83%
2,010 $407,000
Q4 2019

Jan 30, 2020

BUY
$189.21 - $243.2 $352,687 - $453,324
1,864 New
1,864 $449,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sunburst Financial Group, LLC Portfolio

Follow Sunburst Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunburst Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunburst Financial Group, LLC with notifications on news.